北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第三临床医学院  > 肿瘤放疗科  > 期刊论文
学科主题: 临床医学
题名:
The investigation of I-125 seed implantation as a salvage modality for unresectable pancreatic carcinoma
作者: Wang, Hao1; Wang, Junjie1; Jiang, Yuliang1; Li, Jinna1; Tian, Suqing1; Ran, Weiqiang2; Xiu, Dianrong3; Gao, Yang1
关键词: I-125 seed ; Intraoperative implantation ; Ultrasound-guided ; Unresectable ; Pancreatic carcinoma
刊名: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
发表日期: 2013-12-27
DOI: 10.1186/1756-9966-32-106
卷: 32
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Oncology
研究领域[WOS]: Oncology
关键词[WOS]: EXTERNAL-BEAM RADIATION ; PROTRACTED 5-FLUOROURACIL INFUSION ; PHASE-II ; INTRAOPERATIVE RADIOTHERAPY ; CONCURRENT RADIOTHERAPY ; SURGICAL RESECTION ; BYPASS PROCEDURES ; I125 IMPLANT ; CANCER ; ADENOCARCINOMA
英文摘要:

Background: To assess the efficacy of intraoperative ultrasound-guided implantation of I-125 seeds for the treatment of unresectable pancreatic carcinoma, and analyze the associated prognostic factors.

Methods: Twenty-eight patients with pancreatic carcinoma who underwent laparotomy and were considered to have unresectable tumors were included in this study. Nine patients were pathologically diagnosed with Stage II disease, and nineteen patients with Stage III disease. Twenty-eight patients received intraoperative ultrasound-guided I-125 seed implantation and received a D-90 (at least 90% of the tumor volume received the reference dose) ranging from 60 to 163 Gy, with a median of 120 Gy. Seven patients received an additional 35-50 Gy external beam radiotherapy after seed implantation, and ten patients received two to ten cycles of chemotherapy. Overall survival of the patients was calculated and prognostic factors were evaluated.

Results: Of the patients, 94.1% (16/17) achieved good to medium pain relief. The tumor response rate was 78.6% (22/28), and local control was achieved in 85.7% (24/28) of patients. The 1-, 2- and 3-year survival rates were 30%, 11% and 4%, and the median survival was 10.1 months (95% CI: 9.0-10.9). Analysis using the Cox proportional hazards model suggested that patients younger than 60 years and patients who received a D-90 higher than 110 Gy may survive for a longer period.

Conclusions: I seed implantation provides a safe and effective method to relieve pain, control local tumor growth and, to some extent, prolong the survival of patients with stage II and III pancreatic disease, without additional complications. Age and accumulated dose may be factors predictive of a favorable outcome for patients with unresectable pancreatic carcinoma treated with I-125 seeds. These findings need to be validated by conducting further studies with larger cohorts.

语种: 英语
所属项目编号: 81071834
项目资助者: National Science Foundation of China
WOS记录号: WOS:000331739400002
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/59215
Appears in Collections:北京大学第三临床医学院_肿瘤放疗科_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Peking Univ, Hosp 3, Dept Surg, Beijing 100083, Peoples R China
2.Peking Univ, Hosp 3, Dept Radiat Oncol, Beijing 100083, Peoples R China
3.Peking Univ, Hosp 3, Dept Ultrasound, Beijing 100083, Peoples R China

Recommended Citation:
Wang, Hao,Wang, Junjie,Jiang, Yuliang,et al. The investigation of I-125 seed implantation as a salvage modality for unresectable pancreatic carcinoma[J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH,2013,32.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Wang, Hao]'s Articles
[Wang, Junjie]'s Articles
[Jiang, Yuliang]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Wang, Hao]‘s Articles
[Wang, Junjie]‘s Articles
[Jiang, Yuliang]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace